Dipexium Pharmaceuticals

Dipexium Pharmaceuticals is a biopharmaceutical company that develops and commercializes small peptide anti-infective agents, including pexiganan. It offers Locilex, a small peptide topical antibiotic used to treat mild to moderate skin infections in superficial wounds, including infected pressure ulcers, infected burns, infected surgical wounds, and nasal colonization of methicillin-resistant Staphylococcus aureus (MRSA).